While I just jumped into watching BioTech stocks relatively recently, I’m really enjoying the market. With that said, I’ve picked out a few that I’ll be watching closely tomorrow; and I figured I’d share them in advance. So, here they are…
# 1: In BioTech Stocks To Watch: Amarin (NASDAQ: AMRN)
What To Watch For Tomorrow – Tomorrow, Amarin (NASDAQ: AMRN) will most likely have a strong day. However, if you’re following the trends, be very careful. Fast growth means that there could be a correction tomorrow or Friday that will put things back on a more natural scale. Overall, this is a great long-term investment option!
# 2: In BioTech Stocks To Watch: MannKind (NASDAQ: MNKD)
Outlook – MannKind (NASDAQ: MNKD) is a great company that’s gotten a bit of a bad rap recently following a controversial downgrade by Goldman Sachs. While much of the growth today was most likely caused by the positive news from the Federal Reserve, I have to say, I’m hoping for a long-term come back.
# 3: In BioTech Stocks To Watch: Herbalife (NYSE: HLF)
After a positive response from the courts with regard to fraud, Herbalife (NYSE: HLF) stocks have been soaring. Today, the stock is up 12.58% closing the day off at $38.76 per share.
Outlook – Herbalife (NYSE: HLF) is a great company that’s has been going through a bit of a rough patch due to Bill Ackman’s false claims of pyramid schemes. Nonetheless, I think that today’s and past verdicts have proven that Herbalife (NYSE: HLF) isn’t out to scam anyone. Overall, I think we’ll see growth in the long run here as well.
# 4: In BioTech Stocks To Watch: Gilead Sciences (NASDAQ: GILD)
Gilead Sciences (NASDAQ: GILD) had a tough day in the market. While there was a bit of a rally at the end of the day, it wasn’t enough to bring the stock into the green. After falling 0.16% today, Gilead Sciences (NASDAQ: GILD) closed the day off at $100.28 per share.
Outlook – Gilead Sciences (NASDAQ: GILD) is a great company that has made numerous medical advances. While a policy shift in the price of medication could harm dollars in the short term, this is another option that seems primed for long term growth.
# 5: In BioTech Stocks To Watch: Genetic Technologies (NASDAQ: GENE)
Genetic Technologies (NASDAQ: GENE) has had a hard time with share dilution lately. Unfortunately for investors, the downtrends continued today. After losing 9.09%, Genetic Technologies (NASDAQ: GENE) closed the day off at $3.90 per share.
Outlook – Genetic Technologies (NASDAQ: GENE) may be hurting with regard to the short term, but that is because they raised a ton of money; leading to share dilution. In the long run, the company is more poised for growth now than it was before the shares got diluted. So, it may be time to start looking for the bottom of the trend to get in at a great price.
What BioTech Stocks Will You Be Watching Tomorrow?
Let us know in the comments below!